Caribou Biosciences Statistics
Total Valuation
CRBU has a market cap or net worth of $102.77 million. The enterprise value is -$120.13 million.
Important Dates
The last earnings date was Monday, March 10, 2025, after market close.
Earnings Date | Mar 10, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CRBU has 93.00 million shares outstanding. The number of shares has increased by 22.37% in one year.
Current Share Class | 93.00M |
Shares Outstanding | 93.00M |
Shares Change (YoY) | +22.37% |
Shares Change (QoQ) | +0.78% |
Owned by Insiders (%) | 4.68% |
Owned by Institutions (%) | 60.09% |
Float | 81.51M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 9.99 |
Forward PS | 9.28 |
PB Ratio | 0.40 |
P/TBV Ratio | 0.41 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.16, with a Debt / Equity ratio of 0.10.
Current Ratio | 7.16 |
Quick Ratio | 6.94 |
Debt / Equity | 0.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -47.99% and return on invested capital (ROIC) is -30.86%.
Return on Equity (ROE) | -47.99% |
Return on Assets (ROA) | -27.94% |
Return on Invested Capital (ROIC) | -30.86% |
Return on Capital Employed (ROCE) | -58.95% |
Revenue Per Employee | $63,253 |
Profits Per Employee | -$943,703 |
Employee Count | 158 |
Asset Turnover | 0.03 |
Inventory Turnover | n/a |
Taxes
Income Tax | -9,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.11% in the last 52 weeks. The beta is 2.34, so CRBU's price volatility has been higher than the market average.
Beta (5Y) | 2.34 |
52-Week Price Change | -85.11% |
50-Day Moving Average | 1.43 |
200-Day Moving Average | 1.91 |
Relative Strength Index (RSI) | 33.36 |
Average Volume (20 Days) | 1,042,210 |
Short Selling Information
The latest short interest is 8.91 million, so 9.58% of the outstanding shares have been sold short.
Short Interest | 8.91M |
Short Previous Month | 8.86M |
Short % of Shares Out | 9.58% |
Short % of Float | 10.93% |
Short Ratio (days to cover) | 6.59 |
Income Statement
In the last 12 months, CRBU had revenue of $9.99 million and -$149.11 million in losses. Loss per share was -$1.65.
Revenue | 9.99M |
Gross Profit | 9.99M |
Operating Income | -166.62M |
Pretax Income | -123.25M |
Net Income | -149.11M |
EBITDA | -162.69M |
EBIT | -166.62M |
Loss Per Share | -$1.65 |
Full Income Statement Balance Sheet
The company has $209.54 million in cash and $26.49 million in debt, giving a net cash position of $222.90 million or $2.40 per share.
Cash & Cash Equivalents | 209.54M |
Total Debt | 26.49M |
Net Cash | 222.90M |
Net Cash Per Share | $2.40 |
Equity (Book Value) | 252.95M |
Book Value Per Share | 2.74 |
Working Capital | 188.73M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$138.20 million and capital expenditures -$4.88 million, giving a free cash flow of -$143.08 million.
Operating Cash Flow | -138.20M |
Capital Expenditures | -4.88M |
Free Cash Flow | -143.08M |
FCF Per Share | -$1.54 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -1,667.16% |
Pretax Margin | -1,492.04% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |